Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1,404.58% | 130.59% | -164.48% | 81.43% | -1,922.02% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -37.30% | -35.53% | 11.76% | -30.02% | 148.37% |
| Total Other Non-Cash Items | 305.55% | -1,177.33% | 86.84% | -11.72% | 40.74% |
| Change in Net Operating Assets | 6,248.57% | -148.84% | -79.33% | -76.11% | 3,582.40% |
| Cash from Operations | 90.76% | -1.94% | -102.61% | 77.03% | -40.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -105.28% | -39.00% | 400.00% | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | -216.67% | 40.00% | 87.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -222.22% | -9,100.00% | 100.06% |
| Cash from Financing | -98.75% | -12.10% | 567.31% | 204.42% | -103.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.91% | -129.73% | 136.63% | 85.89% | -188.47% |
